Martingale Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,587
| Closed | -$86K | – | 945 |
|
|
2017
Q1 | $86K | Hold |
1,587
| – | – | ﹤0.01% | 927 |
|
|
2016
Q4 | $85K | Sell |
1,587
-103
| -6% | -$5.52K | ﹤0.01% | 952 |
|
|
2016
Q3 | $103K | Sell |
1,690
-1
| -0.1% | -$61 | ﹤0.01% | 939 |
|
|
2016
Q2 | $112K | Hold |
1,691
| – | – | ﹤0.01% | 824 |
|
|
2016
Q1 | $96K | Sell |
1,691
-40
| -2% | -$2.27K | ﹤0.01% | 792 |
|
|
2015
Q4 | $408K | Buy |
1,731
+60
| +4% | +$14.1K | 0.01% | 695 |
|
|
2015
Q3 | $265K | Hold |
1,671
| – | – | 0.01% | 763 |
|
|
2015
Q2 | $633K | Buy |
1,671
+96
| +6% | +$36.4K | 0.01% | 639 |
|
|
2015
Q1 | $659K | Buy |
+1,575
| New | +$659K | 0.02% | 643 |
|